vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and AdvanSix Inc. (ASIX). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $270.6M, roughly 1.3× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs -0.8%, a 17.4% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 9.4%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $36.1M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 3.4%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
ALAB vs ASIX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $359.9M |
| Net Profit | $45.0M | $-2.8M |
| Gross Margin | 75.6% | 7.6% |
| Operating Margin | 24.7% | -0.7% |
| Net Margin | 16.6% | -0.8% |
| Revenue YoY | 91.8% | 9.4% |
| Net Profit YoY | 82.0% | -892.9% |
| EPS (diluted) | $0.25 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $359.9M | ||
| Q3 25 | $230.6M | $374.5M | ||
| Q2 25 | $191.9M | $410.0M | ||
| Q1 25 | $159.4M | $377.8M | ||
| Q4 24 | $141.1M | $329.1M | ||
| Q3 24 | $113.1M | $398.2M | ||
| Q2 24 | $76.8M | $453.5M | ||
| Q1 24 | $65.3M | $336.8M |
| Q4 25 | $45.0M | $-2.8M | ||
| Q3 25 | $91.1M | $-2.6M | ||
| Q2 25 | $51.2M | $31.4M | ||
| Q1 25 | $31.8M | $23.3M | ||
| Q4 24 | $24.7M | $352.0K | ||
| Q3 24 | $-7.6M | $22.3M | ||
| Q2 24 | $-7.5M | $38.9M | ||
| Q1 24 | $-93.0M | $-17.4M |
| Q4 25 | 75.6% | 7.6% | ||
| Q3 25 | 76.2% | 6.8% | ||
| Q2 25 | 75.8% | 14.3% | ||
| Q1 25 | 74.9% | 14.2% | ||
| Q4 24 | 74.0% | 3.4% | ||
| Q3 24 | 77.7% | 14.4% | ||
| Q2 24 | 77.9% | 17.9% | ||
| Q1 24 | 77.4% | 0.9% |
| Q4 25 | 24.7% | -0.7% | ||
| Q3 25 | 24.0% | -0.9% | ||
| Q2 25 | 20.7% | 7.7% | ||
| Q1 25 | 7.1% | 7.7% | ||
| Q4 24 | 0.1% | -3.9% | ||
| Q3 24 | -7.9% | 7.5% | ||
| Q2 24 | -31.7% | 11.5% | ||
| Q1 24 | -127.1% | -7.0% |
| Q4 25 | 16.6% | -0.8% | ||
| Q3 25 | 39.5% | -0.7% | ||
| Q2 25 | 26.7% | 7.7% | ||
| Q1 25 | 20.0% | 6.2% | ||
| Q4 24 | 17.5% | 0.1% | ||
| Q3 24 | -6.7% | 5.6% | ||
| Q2 24 | -9.8% | 8.6% | ||
| Q1 24 | -142.5% | -5.2% |
| Q4 25 | $0.25 | $-0.11 | ||
| Q3 25 | $0.50 | $-0.10 | ||
| Q2 25 | $0.29 | $1.15 | ||
| Q1 25 | $0.18 | $0.86 | ||
| Q4 24 | $1.23 | $0.02 | ||
| Q3 24 | $-0.05 | $0.82 | ||
| Q2 24 | $-0.05 | $1.43 | ||
| Q1 24 | $-1.77 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $19.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $815.2M |
| Total Assets | $1.5B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $19.8M | ||
| Q3 25 | $140.4M | $23.7M | ||
| Q2 25 | $162.3M | $18.4M | ||
| Q1 25 | $86.4M | $8.3M | ||
| Q4 24 | $79.6M | $19.6M | ||
| Q3 24 | $126.1M | $17.3M | ||
| Q2 24 | $421.1M | $12.1M | ||
| Q1 24 | $696.1M | $20.6M |
| Q4 25 | $1.4B | $815.2M | ||
| Q3 25 | $1.3B | $818.2M | ||
| Q2 25 | $1.1B | $823.7M | ||
| Q1 25 | $1.0B | $794.4M | ||
| Q4 24 | $964.8M | $774.6M | ||
| Q3 24 | $889.6M | $766.4M | ||
| Q2 24 | $845.3M | $746.6M | ||
| Q1 24 | $808.8M | $713.2M |
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $983.1M | $1.5B | ||
| Q2 24 | $915.5M | $1.5B | ||
| Q1 24 | $864.9M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $63.7M |
| Free Cash FlowOCF − Capex | $76.6M | $36.1M |
| FCF MarginFCF / Revenue | 28.3% | 10.0% |
| Capex IntensityCapex / Revenue | 6.9% | 7.7% |
| Cash ConversionOCF / Net Profit | 2.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $6.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $63.7M | ||
| Q3 25 | $78.2M | $26.6M | ||
| Q2 25 | $135.4M | $21.1M | ||
| Q1 25 | $10.5M | $11.4M | ||
| Q4 24 | $39.7M | $64.2M | ||
| Q3 24 | $63.5M | $57.3M | ||
| Q2 24 | $29.8M | $50.2M | ||
| Q1 24 | $3.7M | $-36.2M |
| Q4 25 | $76.6M | $36.1M | ||
| Q3 25 | $65.9M | $66.0K | ||
| Q2 25 | $133.3M | $-7.2M | ||
| Q1 25 | $6.0M | $-22.6M | ||
| Q4 24 | $24.3M | $29.8M | ||
| Q3 24 | $46.8M | $26.8M | ||
| Q2 24 | $28.5M | $16.7M | ||
| Q1 24 | $228.0K | $-71.6M |
| Q4 25 | 28.3% | 10.0% | ||
| Q3 25 | 28.6% | 0.0% | ||
| Q2 25 | 69.5% | -1.7% | ||
| Q1 25 | 3.7% | -6.0% | ||
| Q4 24 | 17.2% | 9.1% | ||
| Q3 24 | 41.4% | 6.7% | ||
| Q2 24 | 37.1% | 3.7% | ||
| Q1 24 | 0.3% | -21.3% |
| Q4 25 | 6.9% | 7.7% | ||
| Q3 25 | 5.3% | 7.1% | ||
| Q2 25 | 1.1% | 6.9% | ||
| Q1 25 | 2.8% | 9.0% | ||
| Q4 24 | 10.9% | 10.4% | ||
| Q3 24 | 14.8% | 7.7% | ||
| Q2 24 | 1.7% | 7.4% | ||
| Q1 24 | 5.2% | 10.5% |
| Q4 25 | 2.12× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 2.64× | 0.67× | ||
| Q1 25 | 0.33× | 0.49× | ||
| Q4 24 | 1.61× | 182.29× | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALAB
Segment breakdown not available.
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
